March 26th 2012
Complementary! Sounds good, how could it hurt? When applied in cancer therapy, however, what sounds good may not always be good for patients.
February 24th 2012
In 2011, the FDA reported 232 cancer therapies to be in limited supply. As a result, many patients have had therapies delayed or discontinued, and in some cases, patients have been left without access to appropriate alternatives.
January 30th 2012
Much has been made of the difficulties companies, investigators, and patient advocates have in providing access to novel therapies.
December 21st 2011
The FDA has broad authority to regulate food safety, as well as the safety, efficacy, and utilization of drugs and medical devices.
December 5th 2011
A look at tweaking the corruptive influence of the virus information code to selectively corrupt cancer cells while sparing (normal) cells that do not have a specific cancer phenotype.
September 23rd 2011
In vitro cell manipulation has unleashed the therapeutic potential of human cells.
August 8th 2011
In the context of caring for cancer patients, all physicians and nurses trained in oncology receive education in quality-of-life issues; however, prolonging quantity of life remains our ultimate goal.
July 22nd 2011
Oncologists need to prepare for a new era in which rapidly advancing genetic technology will change the way cancer is treated.
June 14th 2011
Recently, significant attention has been focused on dark energy, despite our inability to directly detect it, because it represents 72% of everything in the universe
May 20th 2011
The explosion of knowledge emanating from laboratories and clinics across the globe is steadily clearing the "haze" that shrouds the molecular basis of malignant cell transformation, growth, and spread